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ABSTRACT 
We observed the clinical and microbiological characteristics of several stages of bloodstream infec-
tions (BSI), as well as the mortality attributed to it in a tertiary hospital in the northeast of Brazil 
(in the city of Maceió, Alagoas). A prospective cohort of 143 patients who had at least one positive 
blood culture was enrolled in the study. Their clinical evolution was followed up for 30 days from 
October 2005 to December 2006. The relation among the qualitative variables was verifi ed through 
Chi-square test. The signifi cance level was 5%. The statistical package adopted was SPSS 15.0 for 
Windows. Up to the thirtieth day, 30.1% of the patients presented bacteremia and 69.9% developed 
sepsis. Among these, 20.3% developed severe sepsis and 10.5% septic shock. The mortality attributed 
to it was 37.8%. In bacteremia, sepsis, severe sepsis, and septic shock conditions, mortality rates were 
9.3%, 50%, 65.5%, and 84.6%, respectively. Respiratory (32.2%) and urinary (14%) sources and the 
ones related to central venous catheter (14%) were prevalent. In the wards 55.12% of the cases devel-
oped sepsis, whereas in the intensive care units, the rate was 87.69% (p < 0.05). Chronic renal failure, 
diabetes melitus, and neuropathy were present in 21.7%, 26.6%, and 29.4% of the cases, respectively. 
Coagulase-negative Staphylococcus (25.9%), Staphylococcus aureus (21%), and Klebsiella pneumoniae 
(14%) were the most present microorganism in the sample. The high morbidity and mortality rates 
in this study are attributed to the lack of knowledge on BSI characteristics and on instituted proto-
cols for detection and treatment in early stages.
Keywords: bloodstream infections, blood cultures, bacteremia, spesis.
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INTRODUCTION
The aging process of the population combined 
with technological advances and survival qual-
ity of immunosuppressed and severely ill pa-
tients has led to a signifi cant increase in the 
incidence of mortality due to bloodstream 
infections (BSI) in recent years, posing major 
problems to public health all over the world, 
both economically and socially.1-4 
However, the actual impact of such dis-
ease has not been widely established in distinct 
communities. It is mandatory that specialists in 
the area collect epidemiological data in order 
to provide authorities and health professionals 
contextualized and more based information re-
garding the extent of problem locally. The con-
cern among health professionals about using 
empirical therapeutics of large spectrum, due 
to lack of knowledge about evolution, the clini-
cal and microbiological characteristics of such 
infections in our hospitals worsened micro-
bial resistance of adverse events and increased 
costs related to it, most of the time without 
decreasing morbidity and mortality of patients 
harmed by disease.
Besides the classic clinical condition, sepsis 
may present as severe sepsis and septic shock. 
Some knowledge about the defi nition criteria 
of the different stages of sepsis among physi-
cians is primordial, once it can promote an 
early diagnosis, immediate treatment, and 
contributes positively in the prognosis of BSI 
patients.5,6 Septic shock and multiorgan dys-
function are the most common causes of death 
in patients with sepsis. The mortality rates as-
sociated with severe sepsis and septic shock de-
scribed in literature are 25% to 30% and 40% 
to 70%, respectively.7,8
Localizing the source of infection is pri-
mordial, considering that the mortality rate 
may vary between 15.4% and 41.2%, depend-
ing on its origin,9 and that empirical antibiotics 
Este é um artigo Open Access sob a licença de CC BY-NC-ND
176
RESULTS
Table 1 shows demographic characteristics of the sample, 
such as gender, age, and origin, number of samples analyzed, 
kind of clinical condition, and place of admission. 
The episodes of bacteremia or candidemias in the 
study meant 68% in all positive culture recorded in the 
headquarters hospital in the research during the period 
studied. Among the specialties that contributed to the 
casuistic, the most prevalent were neurology, cardiology, 
medical clinic and oncology, corresponding to 67.9% of 
the overall analyzed. 
It was observed that 55.12% of the patients with positive 
blood culture developed sepsis in the open settings (individ-
ual rooms and wards), whereas in the closed setting (ICU), 
this rate increased signifi cantly to 87.69% (p < 0.05). Among 
these 14.10% developed severe sepsis in the open settings, 
whereas in the ICU, 27.69% evolved to such complication 
(p < 0.05). Septic shock was present in 6.41% of the patients 
admitted in the open units and in 15.34% in closed units 
(p < 0.05) (Figure 1).
Table 1. Demographic characteristics of the sample 
studied (n = 143 patients related to 68% of overall 
positive samples). Santa Casa de Misericórdia de 
Maceió from October 2005 to December 2006
Variable n %
Gender Male 60.1
 Female 39.9
Clinic Medical 76.9
 Surgical 23.1
Age = 60 yrs 57.3
 > 60 yrs 42.7
 Home 68.5
Origin The very hospital 11.2
 Other hospitals 19.6
Number 
One 38.5
of blood 
Two 16.1
cultures 
Three 45.5
analyzed
 Ward 19.6
 Apartment 35.0
 Coronary ICU 0.7
Admission Neonatal ICU 7.7
setting Pediatric ICU 9.8
 General ICU 11.9
 Neuro ICU 11.9
 Cardiac ICU 3.7
therapy will differ according to the site of infection.10 The 
elderly, immunocompromised, diabetic, individuals with 
dialytic chronic renal failure, alcoholics, and patients admit-
ted in the intensive care unit (ICU) are the main groups at 
risk of developing such infections.11 
In this study, we evaluated the clinical and microbiologi-
cal characteristics of BSI in patients admitted in a tertiary 
hospital in the northeast of Brazil that attends about 49,000 
patients per year in its emergency unit. It has 330 beds, 
of which 47 is for adult and pediatric intensive care units 
(ICU). The incidence of BSI in 2006 was 41.34 cases in 1,000 
discharges. Published data reported lower rates in American 
hospitals, although they have registered an increase from 5% 
to 14% in the last past two decades,12 raising incidence den-
sity from 2-4 episodes to 15-20 per 1,000 discharges. 
The high incidence of BSI and the lack of knowledge of its 
clinical and microbiological characteristics according to its dis-
tinct evolutive stages motivated us to carry out this research. 
The aim of this study is to establish the epidemiological profi le 
of such infections in order to guide towards measures to reduce 
the incidence and mortality due to BSI in our setting.
MATERIAL AND METHODS
We carried out a study of prospective panel in which we as-
sessed 143 patients with positive blood cultures, in a tertiary 
hospital in Maceió, Alagoas, northeast of Brazil, from Oc-
tober 2005 to December 2006. Patients of all ages and both 
genders who were admitted to medical wards and ICU were 
enrolled in the study. They presented at least one positive 
blood culture and remained in the hospital for at least 24 
hours. Sixty fi ve cases of positive blood culture of patients 
who were either transferred or died within the fi rst 24 hours 
of evolution, or yet had not signed the informed consent 
were excluded. The identifi cation data, characteristics, and 
disease evolution were recorded systematically up to the 
thirtieth day of evolution in a protocol developed for this 
very purpose and then submitted to statistical studies. The 
defi nitions for sepsis and its variations were in accordance 
with the American College of Physicians and the Society of 
Critical Care Medicine, 1991.13 The adult ICU patients were 
grouped in 5 categories: A, B, C, D, E, whose estimated risks 
are 4.9%, 11.5%, 25.1%, 29.9%, and 42.4%, respectively, 
according to the prediction system for infection risk “Aver-
age Score of Illness System” (ASIS), modifi ed by Pinheiro.14
Descriptive analysis of all variables in the study was per-
formed. Qualitative variables were presented in terms of their 
absolute and relative values. Quantitative variables were pre-
sented according to their central tendency and dispersion. In 
order to verify the relationship among the qualitative vari-
ables, Chi-square test was applied. The level of signifi cance 
was 5%. The statistical package was SPSS15.0 for Windows. 
This study was approved by the UNCISAL Research Ethics 
Committee under the protocol number 430. 
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Figure1: Clinical evolution of patients with positive blood 
culture in open ans closed admission settings during the 
period studied. Santa Casa de Misericórdia de Maceió from 
October 2005 to December 2006.
Positive blood 
cultures
Open settings 
54.6%
Closed settings 
45.4%
Sepsis                       Bacteremias                  Sepsis                        Bacteremias 
55.1%                        44.9%                            87.7%                         12.3%
Severe sepsis           Septic shock                Severe sepsis           Septic shock
25.6%                       11.6%                            31.6%                     17.5%
In this casuistic, 30.1% of the patients presented only 
bacteremia and 69.9% developed sepsis. Among these, 20.3% 
developed severe sepsis and 10.5% septic shock by the thirti-
eth day of follow up after BSI detection. On the thirtieth day, 
39.9% of the patients had been discharged, 37.8% died, and 
22.4% remained in the hospital. 
Figure 2 shows the evolution of patients from admission 
to discharge, death, and the ones who remained in the hospi-
tal by the thirtieth day, after the collection of blood culture. 
At that time, they had only presented bacteremia or had de-
veloped distinct progressive stages of sepsis during the peri-
od studied. Up to the thirtieth day, none of the patients who 
presented septic shock were discharged; however, 84.6% of 
the patients in this group died, and 15.4% remained in the 
hospital for this period.
Figure 2: Evolution of patients up to 30th day of follow up, 
when they had presented only bacteremia, and when they 
evolved to sepsis, severe sepsis and septic shock. Santa Casa 
de Misericórdia de Maceió from October 2005 to December 
2006 (n = 143).
Bacteremia         Sepsis Severe   Sepsis Septic      Shock
Inpacient
Discharge
9,30%
76,70%
65,50%
27,60%
6,90%
84,60%
15,40%
50,00%
26,00%
24,00%
14,00%
DISCUSSION
Understanding basic concepts on the several ways the pa-
thology may occur is crucial in order to manage it. Different 
from other diseases, sepsis may represent clinical conditions 
in its evolutive aspect distinct from those of physiopatholog-
ical condition.15 Aiming to standardize concepts, the Ameri-
can College of Physicians and the Society of Critical Care 
Medicine elaborated a consensus for sepsis defi nitions and 
its clinical variation in 1991.13
The fi rst American epidemiological study that used the 
1991 Consensus defi nition about sepsis clinical variation is 
the study by Rangel-Frausto’s et al.16 This study showed the 
incidence of BSI (68%), of which 17% developed sepsis, 13% 
severe sepsis, and only 3% developed septic shock. More re-
cently, Albert et al.17 observed that 8.2% of the cases studied 
developed septic shock. In our study, sepsis was present in 
It was observed that, among patients from adult ICU, 
the susceptibility to infection development was higher than 
29.9% (categories D and E) in 36.0% of the cases.
Among the comorbidities, it was verifi ed that diabetes 
mellitus was incident in 26.6% of the cases, chronic renal 
failure in 21.7%, neuropathy in 29.4%, chronic obstructive 
pulmonary disease (COPD) in 11.2%, neoplasia in 17.9%, 
and neutropenia in 8.4%.
The main etiological agents isolated in blood culture of 
patients in this study were Coagulase-negative Staphyloco-
ccus (CNS) 25.9%, Staphylococcus aureus (21%), Klebsiella 
pneumoniae (14%), Escherichia coli (9.1%), and Candida 
spp. (8.4%). 
The main pathogen isolated from blood cultures of pa-
tients who died was S. aureus, present in 24.1% of the cases. 
In addition, only 17.5% of BSI patients due to S. aureus were 
discharged by the thirtieth day of follow-up. On the other 
hand, Coagulase-negative Staphylococcus (CNS) showed 
important correlation, considering evolution to discharge 
(38.6%) in this research. 
Sources that contributed most to mortality in this study 
were respiratory tract (37%), urinary (16.7%), and intra-
abdominal (11.1%). It was observed that the respiratory 
source was a predictor to evolution from bacteremia to sep-
sis, considering that its presence (36.0%) was signifi cant 
when compared to other sources responsible for infection 
(p < 0.05).
It was observed that 60.8% of the patients in the sam-
ple used antibacterial drugs and 4.9% received antifungal 
drugs before the occurrence of bacteremia and candidemia. 
All patients who developed multiresistant microorganisms 
in blood cultures had undergone at least one antimicrobial 
treatment a couple of weeks before the occurrence of bac-
teremia (92.6% with therapeutic purpose and 7.4% as pro-
phylactic). 
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70% of BSI episodes. Severe sepsis corresponded to 20.3% 
of the population under study, and 10.5% of the cases devel-
oped septic shock. 
The sample demographic characteristics showed that 
male was predominant in 60.1%, among the 143 patients 
who took part of the study. A similar fi nding published by 
Martin et al.18 confi rmed this predisposition when both 
genders were compared. In relation to mortality, it was veri-
fi ed that patients who developed severe sepsis and septic 
shock and were older than 60 had a mortality rate of 86.7% 
(p < 0.05; relative risk of 8.7), against 50% when all ages were 
included (p < 0.05; relative risk of 5.4%). Lemos et al.19 found 
that the elderly were the principal risk group for BSI develop-
ment and for the increase of morbidity ad mortality. 
Brun-Buisson et al.20 in their study on the relationship 
between bacteremia and severe sepsis in French hospitals 
identifi ed patient’s age, intra-abdominal and pulmonary 
septic sources among other independent risks. In our study, 
we also highlighted that, when the respiratory source was 
present, the development of sepsis was signifi cant in 78.3% 
of the cases (p < 0.05). Moreover, the absence of respira-
tory source as BSI origin was so signifi cant that patients 
did not develop the most severe degrees of such pathology 
(p = 0.020).
According to Medeiros et al.,21 the presence and severity 
of base pathologies, such as chronic obstructive pulmonary 
disease, diabetes mellitus, chronic renal failure, congestive 
cardiac failure, and the consequent need for invasive pro-
cedures favored colonization of microorganisms, predispos-
ing patients to the development of infections. In our study, 
patients who had cardiovascular pathologies presented 
signifi cant correlation between comorbidity and respira-
tory source, presenting 65.2% of the cases in this condition 
(p < 0.05). 
Chronic renal failure showed a prevalence of 21.7% in 
this study, having 61.3% of these patients under dialysis by 
the time they had bacteremia/candidemia. Among the pa-
tients who presented positive blood culture, 14% had dia-
lytic chronic renal failure. Diabetes mellitus was incident in 
26.6% of the cases and 11.2% of the patients had chronic 
obstructive pulmonary disease. 
S. aureus were isolated in 21% of the samples analyzed 
in patients with sepsis, corresponding to 70% of posi-
tive cultures for this pathogen in diagnosed BSI, of which 
50% were methicillin-resistant (MRSA). This frequency 
presented statistical signifi cance (p < 0.05) in relation to 
the other pathogens identifi ed in this group. NNIS data, 
published by CDC,22 reported that 59.5% of the isolated 
S.aureus in American hospitals was methicillin-resistant. 
Recent studies suggest that the epidemiology of MRSA 
may get worse, once the isolation of these strains is no 
more limited to hospital environment, having spread out 
to the community.23,24 
Concerning patients’ clinical evolution in different set-
tings of the hospital, it was observed that, in the open ones, 
14.10% of the patients developed severe sepsis. However, 
when ICU were analyzed separately, it was verifi ed that 
27.69% of the patients developed severe sepsis (p <0.05), 
showing two times more the incidence in open settings. It 
reﬂ ects the susceptibility of patients admitted in such units 
in accordance with infection risk prediction ASIS (Average 
of Severity of Illness Score), modifi ed by Pinheiro.14 In this 
study, it was detected that the probability of adult ICU pa-
tients to develop infection is higher than 29.9% (categories 
D and E) in 36.0% of the cases. Among the studies revised by 
Silvia et al.,25 the occurrence rate of severe sepsis was 0.26% 
when ward patients were included, 27% when only ICU pa-
tients were investigated. 
The overall mortality rate in hospital during research was 
3.7%, whereas the mortality due to BSI by the thirtieth day 
of follow up was 37.8%. Data based on literature25,26 showed 
overall mortality around 30%, similar to the fi ndings in our 
study. However, it was observed that among patients who 
presented sepsis, 50% died by the thirtieth day after diagno-
sis. Data published in Spain in 199326 presented a mortality 
rate of 65.7%, straightly linked to sepsis. Mortality rate due 
to sepsis in BASES study was 33.9%,27 whereas Brun-Buisson 
et al.20,28 observed death probability of 25% by the 28th day. 
It was observed that on the thirtieth day after diagnosis for 
severe sepsis, 65.5% of the patients died, presenting a higher 
rate than in literature analyzed. Rangel-Frausto et al.16 ob-
served a mortality rate of 20% in their study. Sands et al.29 
found a rate of 34% by the 28th day of evolution, and BASES 
study showed a mortality rate of 46.9% for severe sepsis.27 
In cases of septic shock, 84.6% of the patients in our study 
had died by the 30th day of follow up. The mortality rate 
was 52.2% in BASES study27 and varied between 47.2% and 
63.8% in the study by Alberti et al.17
The high rates of evolution to more severe stages of se-
vere sepsis and mortality attributed to these conditions in this 
study can be a consequence of the lack of knowledge on BSI 
characteristics in our area and the absence of instituted proto-
cols in hospitals. Several studies report that the lack of knowl-
edge of such aspects contributes to the increase of morbidity 
and mortality of patients affected by this infection.6,9,10
In 2004, Dellinger30 proposed a Surviving Sepsis Cam-
paign Guidelines for Management of Severe Sepsis and 
Septic Shock in order to establish a model based on better 
scientifi c evidences available to manage patients with sepsis 
and septic shock. According to him, not changing medical 
behavior practice at bedside, despite the alarming levels of 
BSI incidence and mortality, means an unforgivable fail-
ure. In 2008, it was published in Critical Care31 an update 
on these guidelines proposing key recommendations, listed 
by categories of evidence to help in management of severe 
sepsis and septic shock.
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We understand that the early diagnosis of the different 
stages of BSI and the institution of adequate and immedi-
ate treatment are essential in order to avoid the evolution 
to more severe, and many times, irreversible stages of the 
disease.
CONCLUSION
According to the study, the most relevant characteristics that 
may lead to increase of morbidity and mortality rates due 
to BSI were the presence of respiratory source of infection, 
isolation of S. aureus in blood cultures, age of patients older 
than 60 years, and severity of patients in ICU. Being aware 
of such results may contribute to the adoption of preventive 
measures and effective therapeutics capable to improve the 
survival of BSI patients. 
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